NCT05380245View on ClinicalTrials.gov

Drug-Drug Interaction Study of Voriconazole With Clarithromycin.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

November 16, 2018

Study Completion Date

November 30, 2018

Conditions

Healthy

Interventions

DRUG

Voriconazole 200 mg x 2 Tablets

Name of medication of Reference Formulation: Tablets Voriconazole Vfend®, 200 mg by Pfizer, Inc. (USA), (Batch No: 00005505; Mfg. date 09/2016).

DRUG

Clarithromycin 500 mg x 1Tablets

Name of medication of Intervention Formulation: Tablet Klaricid, 500 mg by Abbott, Lab Pvt. Ltd. (Karachi, Pakistan), Batch No: 81573XU; Mfg. date 10/2017.

Trial Locations (1)

25000

Medical Dispensary, Abdul Wali Khan University Mardan, Pakistan., Mardan

All Listed Sponsors

lead

Abdul Wali Khan University Mardan

OTHER

NCT05380245 - Drug-Drug Interaction Study of Voriconazole With Clarithromycin. | Biotech Hunter | Biotech Hunter